EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient‐specific quality assurance for extremely small field sizes using 3D in vivo dosimetry in fractionated stereotactic radiosurgery for brain metastases

Kenichi Jumonji, Jun Takatsu iD, Naoya Hara, Ruiheng Fan, Risa Shimomura, Tatsuya Inoue iD, Kotaro Iijima, Noriyuki Okonogi, Naoya Murakami, Naoto Shikama

Journal of Applied Clinical Medical Physics · 2026

DOI: 10.1002/acm2.70417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2026. Verfasst von Kenichi Jumonji und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Radiosurgery, Radiotherapy Planning, Computer-Assisted, Quality Assurance, Health Care, Brain Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fractionated stereotactic radiosurgery (fSRS) using LINAC‐based volumetric‐modulated arc therapy (VMAT) has become widely adopted and achieved favorable outcomes. However, this technique involves extremely small field sizes, making pre‐treatment quality assurance (QA) with high‐resolution detectors essential.

Purpose

This study aimed to evaluate the error detection sensitivity and utility of EPID using 3D in vivo dosimetry based on dose‐volume histogram (DVH) analysis for brain fSRS pre‐treatment QA.

Methods

VMAT plans were generated for spherical planning target volumes (PTVs) with diameters of 1–3 cm centered in SRS MapCHECK. A monitor unit (MU) output error was introduced in increments, and the leaf gap width was systematically opened and closed. Finally, multi‐leaf collimator (MLC) shift errors were applied. The error detection sensitivity was evaluated with these intentional errors. We compared this with the SRS MapCHECK 2D gamma analysis conventionally used in pre‐treatment QA. For in vivo dosimetry, 3D dose calculations were performed with PerFRACTION using cine‐mode electronic portal imaging device images and log files. DVH parameters such as D98%, D95%, D2%, and average doses of the PTV were compared between the base plan and the error plans. The 2D gamma analysis was performed using global gamma of 3%/2 mm, 3%/1 mm, 2%/2 mm, 2%/1 mm, and 1%/1 mm.

Results

The 2D gamma analysis revealed no MU output errors for the 1 cm target across all criteria. The 2%/1 mm criterion effectively detected errors in leaf gap width and MLC shifts in some cases. Conversely, all error types were detected by 3D in vivo dosimetry using D95% of the target.

Conclusion

In pre‐treatment QA for brain fSRS, 3D in vivo dosimetry based on DVH analysis demonstrated superior error detection sensitivity compared to conventional 2D gamma analysis. Our results suggest that 3D in vivo dosimetry is a useful tool for pre‐treatment QA in brain fSRS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryRadiotherapy Planning, Computer-AssistedQuality Assurance, Health CareBrain NeoplasmsRadiotherapy, Intensity-ModulatedImaging, Three-DimensionalIn Vivo DosimetryHumansRadiotherapy DosageRadiometryOrgans at RiskPhantoms, ImagingParticle Accelerators

Stichwörter der Autor:innen

3D in‐vivo dosimetryPerFRACTIONerror detection sensitivitypatient‐specific QAsmall field

Autor:innen und Institutionen

  • Department of Radiation Oncology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
  • Department of Radiology, Tokyo Rosai Hospital, Ohta-ku, Tokyo, Japan.
  • Department of Radiology, Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan.
  • Department of Radiology, Juntendo University Urayasu Hospital, Chiba, Japan.

ORCID-Profile: Jun Takatsu, Tatsuya Inoue

Zitieren

APA

Jumonji, K., Takatsu, J., Hara, N., Fan, R., Shimomura, R., Inoue, T., Iijima, K., Okonogi, N., Murakami, N., & Shikama, N. (2026). Patient‐specific quality assurance for extremely small field sizes using 3D in vivo dosimetry in fractionated stereotactic radiosurgery for brain metastases. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70417

Vancouver

Jumonji K, Takatsu J, Hara N, Fan R, Shimomura R, Inoue T, et al. Patient‐specific quality assurance for extremely small field sizes using 3D in vivo dosimetry in fractionated stereotactic radiosurgery for brain metastases. Journal of Applied Clinical Medical Physics. 2026. doi:10.1002/acm2.70417

BibTeX
@article{Jumonji2026,
  author = {Jumonji, Kenichi and Takatsu, Jun and Hara, Naoya and Fan, Ruiheng and Shimomura, Risa and Inoue, Tatsuya and Iijima, Kotaro and Okonogi, Noriyuki and Murakami, Naoya and Shikama, Naoto},
  title = {Patient‐specific quality assurance for extremely small field sizes using 3D in vivo dosimetry in fractionated stereotactic radiosurgery for brain metastases},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2026},
  doi = {10.1002/acm2.70417}
}
Kostenlos starten →